Adma Biologics (ADMA) Accumulated Expenses (2011 - 2026)
Adma Biologics' Accumulated Expenses came in at $54.22 million for Q3 2026, up 88.1% from $28.83 million a year earlier and up 38.6% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Adma Biologics' Accumulated Expenses was $40.47 million, up 18.7% from FY2024.
- Accumulated Expenses has increased in each of the last ten years, with a five-year compound annual growth rate of 37.1% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $34.11 million in FY2024 (+3.6%), $32.92 million in FY2023 (+31.7%), $24.99 million in FY2022 (+45.2%) and $17.21 million in FY2021 (+105.8%).
- The Q3 2026 figure represents the highest quarterly Accumulated Expenses in data going back to Q2 2011.
- Year-over-year, Accumulated Expenses increased in six of the last eight quarters, with growth averaging 26.2%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q4 2021 (growth of 105.8%), and the weakest in Q2 2026 (a decline of 10.9%).
- Business Quant data shows ADMA's Accumulated Expenses at $39.11 million (Q2 2026), $48.56 million (Q1 2026) and $40.47 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 54.22 Mn |
| Jun 30, 2026 | 39.11 Mn |
| Mar 31, 2026 | 48.56 Mn |
| Dec 31, 2025 | 40.47 Mn |
| Sep 30, 2025 | 28.83 Mn |
| Jun 30, 2025 | 43.90 Mn |
| Mar 31, 2025 | 31.56 Mn |
| Dec 31, 2024 | 34.11 Mn |
| Sep 30, 2024 | 27.54 Mn |
| Jun 30, 2024 | 27.73 Mn |
| Mar 31, 2024 | 33.69 Mn |
| Dec 31, 2023 | 32.92 Mn |
| Sep 30, 2023 | 29.86 Mn |
| Jun 30, 2023 | 28.75 Mn |
| Mar 31, 2023 | 22.67 Mn |
| Dec 31, 2022 | 24.99 Mn |
| Sep 30, 2022 | 18.38 Mn |
| Jun 30, 2022 | 15.96 Mn |
| Mar 31, 2022 | 16.65 Mn |
| Dec 31, 2021 | 17.21 Mn |
API Access
Adma Biologics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();